CLU is down-regulated in the vast majority of primary and naïve cancers in comparison to normal tissue [130,131,132] by epigenetic mechanisms that include CpG islands hypermethylation and histone tail modification [133,134,135,136,137,138]. Here, CLU is linked to cancer.